Table 4. Independent risk factors for GNB in CRBSI in neutropenic oncological and hematological patients.
Adjusted odds ratio (95% CI) | p-value | |
---|---|---|
Older age | 1.016 (1.001–1.033) | 0.043 |
Longer duration of in-situ catheter | 1.007 (1.004–1.011) | <0.001 |
Prior antibiotic therapy with penicilins± | 2.716 (1.366–5.403) | 0.004 |
Current antibiotic therapy with glycopeptides | 1.931 (1.001–3.306) | 0.041 |
±Consisting of piperacillin-tazobactam, amoxicillin, ampicillin, amoxicillin-clavulanate and cloxacillin.